BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10454717)

  • 41. Usefulness of single fiber EMG for distinguishing neuromuscular from other causes of ocular muscle weakness.
    Ukachoke C; Ashby P; Basinski A; Sharpe JA
    Can J Neurol Sci; 1994 May; 21(2):125-8. PubMed ID: 8087737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of myasthenia gravis using electrooculography signals.
    Liang T; Boulos MI; Murray BJ; Krishnan S; Katzberg H; Umapathy K
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():896-899. PubMed ID: 28268468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies.
    Behbehani R; Ali A; Al-Moosa A
    Neuroophthalmology; 2022; 46(4):220-226. PubMed ID: 35859633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maximal respiratory pressures in myasthenia gravis. Relation to single fiber electromyography.
    Fernández CM; Tejedor ED; Frank A; Pino JM; Conde CP; Barreiro P
    Acta Neurol Scand; 2001 Jun; 103(6):392-5. PubMed ID: 11421852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AAEE minimonograph #25: Single-fiber electromyography in myasthenia gravis.
    Sanders DB; Howard JF
    Muscle Nerve; 1986; 9(9):809-19. PubMed ID: 3785290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody profile may predict outcome in ocular myasthenia gravis.
    Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
    Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulated single fiber EMG of the frontalis muscle in the diagnosis of ocular myasthenia.
    Valls-Canals J; Montero J; Pradas J
    Muscle Nerve; 2000 May; 23(5):779-83. PubMed ID: 10797402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.
    Velonakis G; Papadopoulos VE; Karavasilis E; Filippiadis DK; Zouvelou V
    Neuroradiology; 2021 Sep; 63(9):1531-1538. PubMed ID: 34232334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.
    Ding J; Zhao S; Ren K; Dang D; Li H; Wu F; Zhang M; Li Z; Guo J
    BMC Neurol; 2020 Jun; 20(1):238. PubMed ID: 32527235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiologic evaluation of myasthenia gravis and its mimics: real-world experience with single-fiber electromyography.
    Khoo A; Hay Mar H; Borghi MV; Catania S
    Hosp Pract (1995); 2022 Dec; 50(5):373-378. PubMed ID: 36103994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of single fiber electromyography and repetitive nerve stimulation in consecutive patients with myasthenia gravis.
    Srivastava A; Kalita J; Misra UK
    Electromyogr Clin Neurophysiol; 2007; 47(2):93-6. PubMed ID: 17479725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
    Ma R; Cheng Y; Gan L; Zhou X; Qian J
    BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic utility of stimulated single-fiber electromyography of the orbicularis oculi muscle in patients with suspected ocular myasthenia.
    Mercelis R; Merckaert V
    Muscle Nerve; 2011 Feb; 43(2):168-70. PubMed ID: 21254079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrodiagnostic studies in myasthenia gravis.
    Lyu RK; Cheng SY; Tang LM
    Changgeng Yi Xue Za Zhi; 1993 Sep; 16(3):164-9. PubMed ID: 8221289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors for conversion to generalization in ocular myasthenia gravis.
    Witthayaweerasak J; Rattanalert N; Aui-Aree N
    Medicine (Baltimore); 2021 May; 100(19):e25899. PubMed ID: 34106649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.